Insider trades
Abraham Ceesay, CEO of Rapport Therapeutics RAPP, has filed 0 purchases and 28 sales on the open market. Over the past 12 months that comes to a net sale of $1.6M. The latest trade was on 09/23.
Abraham Ceesay
CEO
- Company
- Rapport Therapeutics RAPP
- First filing
- 23/02/08
- Trades
- 41 trades
- Buys / sales
- 0 / 28
- 12-month net buying
- −$1.6M
- Last trade
- 09/23
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
RAPP | Open-market sale10b5-1 plan | 09/23 | 09/24 | 2,210 sh3 trades | $39.17avg. | $86,565.18 | −0.5% |
RAPP | Open-market sale10b5-1 plan | 02/18 | 02/19 | 10,916 sh4 trades | $29.35avg. | $320,365.72 | No record |
RAPP | Open-market sale10b5-1 plan | 01/20 | 01/22 | 10,916 sh2 trades | $26.12avg. | $285,075.09 | No record |
RAPP | Open-market sale10b5-1 plan | 25/12/17 | 25/12/18 | 10,916 sh6 trades | $29.64avg. | $323,526.04 | No record |
RAPP | Open-market sale10b5-1 plan | 25/11/17 | 25/11/18 | 10,916 sh4 trades | $25.20avg. | $275,040.18 | No record |
RAPP | Open-market sale10b5-1 plan | 25/10/15 | 25/10/16 | 10,916 sh4 trades | $25.81avg. | $281,727.23 | No record |
RAPP | Open-market sale10b5-1 plan | 25/09/17 | 25/09/19 | 76,420 sh4 trades | $26.32avg. | $2,011,162 | No record |
| Open-market sale10b5-1 plan | 25/09/04 | 25/09/08 | 2,354 sh | $27.19 | $64,005.26 | −20.7% |
